Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implementation of a molecular tumor board at a regional level to improve access to targeted therapy.
Bourien H, Lespagnol A, Campillo-Gimenez B, Felten-Vinot I, Metges JP, Corre R, Lesimple T, le Marechal C, Boussemart L, Kammerer-Jacquet SF, le Gall E, Denoual F, de Tayrac M, Galibert MD, Mosser J, Edeline J. Bourien H, et al. Among authors: lesimple t. Int J Clin Oncol. 2020 Jul;25(7):1234-1241. doi: 10.1007/s10147-020-01661-6. Epub 2020 Mar 25. Int J Clin Oncol. 2020. PMID: 32215806 Free article.
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer.
Jones RH, Fizazi K, James ND, Tammela TL, Matsubara N, Priou F, Beuzeboc P, Lesimple T, Bono P, Kataja V, Garcia JA, Protheroe A, Shore N, Aspegren J, Joensuu H, Kuss I, Fiala-Buskies S, Vjaters E. Jones RH, et al. Among authors: lesimple t. Prostate Cancer Prostatic Dis. 2024 Dec;27(4):786-789. doi: 10.1038/s41391-023-00740-9. Epub 2023 Oct 26. Prostate Cancer Prostatic Dis. 2024. PMID: 37884613 Free PMC article. Clinical Trial.
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
Long GV, Hauschild A, Santinami M, Kirkwood JM, Atkinson V, Mandala M, Merelli B, Sileni VC, Nyakas M, Haydon A, Dutriaux C, Robert C, Mortier L, Schachter J, Schadendorf D, Lesimple T, Plummer R, Larkin J, Tan M, Adnaik SB, Burgess P, Jandoo T, Dummer R. Long GV, et al. Among authors: lesimple t. N Engl J Med. 2024 Nov 7;391(18):1709-1720. doi: 10.1056/NEJMoa2404139. Epub 2024 Jun 19. N Engl J Med. 2024. PMID: 38899716 Clinical Trial.
ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.
Primot A, Mogha A, Corre S, Roberts K, Debbache J, Adamski H, Dreno B, Khammari A, Lesimple T, Mereau A, Goding CR, Galibert MD. Primot A, et al. Among authors: lesimple t. Pigment Cell Melanoma Res. 2010 Feb;23(1):93-102. doi: 10.1111/j.1755-148X.2009.00652.x. Epub 2009 Nov 6. Pigment Cell Melanoma Res. 2010. PMID: 19895547
A 4-gene signature associated with clinical outcome in high-grade gliomas.
de Tayrac M, Aubry M, Saïkali S, Etcheverry A, Surbled C, Guénot F, Galibert MD, Hamlat A, Lesimple T, Quillien V, Menei P, Mosser J. de Tayrac M, et al. Among authors: lesimple t. Clin Cancer Res. 2011 Jan 15;17(2):317-27. doi: 10.1158/1078-0432.CCR-10-1126. Epub 2011 Jan 11. Clin Cancer Res. 2011. PMID: 21224364
[MGMT analysis in gliomas].
Quillien V, Vauléon E, Saikali S, Lesimple T, Hamlat A, Etcheverry A, Mosser J. Quillien V, et al. Among authors: lesimple t. Bull Cancer. 2011 Mar;98(3):291-303. doi: 10.1684/bdc.2011.1332. Bull Cancer. 2011. PMID: 21459716 Review. French.
Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma.
Pracht M, Mogha A, Lespagnol A, Fautrel A, Mouchet N, Le Gall F, Paumier V, Lefeuvre-Plesse C, Rioux-Leclerc N, Mosser J, Oger E, Adamski H, Galibert MD, Lesimple T. Pracht M, et al. Among authors: lesimple t. J Eur Acad Dermatol Venereol. 2015 Aug;29(8):1530-8. doi: 10.1111/jdv.12910. Epub 2015 Jan 26. J Eur Acad Dermatol Venereol. 2015. PMID: 25623140
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma.
Brunot A, Grob JJ, Jeudy G, Grange F, Guillot B, Kramkimel N, Mortier L, Le Corre Y, Aubin FF, Mansard S, Lebbé C, Blom A, Montaudie H, Giacchero D, Prey S, Legoupil D, Guyot A, Amini-Adle M, Granel-Brocard F, Meyer N, Dinulescu M, Edeline J, Campillo-Gimenez B, Lesimple T. Brunot A, et al. Among authors: lesimple t. JAMA Dermatol. 2020 Sep 1;156(9):982-986. doi: 10.1001/jamadermatol.2020.2149. JAMA Dermatol. 2020. PMID: 32667663 Free PMC article.
Increased thyroid uptake on 18F-FDG PET/CT is associated with the development of permanent hypothyroidism in stage IV melanoma patients treated with anti-PD-1 antibodies.
Frelau A, Palard-Novello X, Jali E, Boussemart L, Dupuy A, James P, Devillers A, Le Jeune F, Edeline J, Lesimple T, Girard A. Frelau A, et al. Among authors: lesimple t. Cancer Immunol Immunother. 2021 Mar;70(3):679-687. doi: 10.1007/s00262-020-02712-7. Epub 2020 Sep 3. Cancer Immunol Immunother. 2021. PMID: 32880684 Free PMC article.
137 results